Lilly edges higher as drug stocks climb

Shares of partners Eli Lilly, Amylin and Alkermes edged higher after Lilly updated its financial outlook on Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.